NEC, Imprivata team for Single Sign On technology

TriMed Staff | | Health Imaging | Screening
Imprivata Inc. of Lexington, Mass. and NEC Solutions America Inc., an affiliate of NEC Corp., have joined forces to market and deliver an integrated system that uses finger point identification to enable enterprise single sign-on.

According to the terms of the agreement, NEC will offer a TouchPass-branded version of the OneSign ESSO applicant in the North American healthcare market. NEC TouchPass - Secure Single Sign-On - combines NEC's biometrics technology and Imprivata's OneSign ESSO.

The integrated biometric-enabled ESSO system allows multiple users to securely share the same workstation. From an IT perspective, the companies said the appliance's Application Profile Generator enables time savings by automatically learning and securing the user-authentication procedures of any Windows-based, client-server, mainframe or Java application.

TriMed Staff

Related Content

FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise
Singing radiologist pens song to clear up confusion about breast cancer screening recs
AI loaded onto mammography systems can flag possible cancers in real time to speed workflows
Over half of eligible women skip their mammogram

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup